title: [Treatment of breast cancer after 70 years of age. Report of 1143 cases].
abstract: OBJECTIVE
  Breast cancer is the most frequent type of cancer in women, increasing in frequency with the elderly. In Europe, a third of new breast cancers occur in women over 70 years of age. The aim of this retrospective study was to analyse the tumoural lesions and therapeutic results in a female population over 70, treated in the same medical centre over a 15-year period.
  
  
  METHODS
  From 1978 to 1992, 1,143 female patients aged 70 or over were treated for a unilateral breast cancer without metastases and followed-up during a mean 6-year period. The initial treatment was surgical in 1,012 patients: radical mastectomy in 95% of the cases with axillary node dissection in 97.6%. Adjuvant radiotherapy was performed in 289 patients and adjuvant treatment with Tamoxifen in 411 patients. The results were compared with those obtained in 2,947 patients aged 50 to 69, treated during the same period in the same medical centre.
  
  
  RESULTS
  The 5-year survival rate in women 70 and over was 80% vs 85.5% in women aged 50 to 69 (P < 0.000001). The same rate of loco-regional recurrences and metastases occurred in both populations. In the patients who initially underwent surgery, after multivariate analysis according to the Cox model, the prognosis factors (similar to those observed in the group of younger women) were: the number of involved nodes (P = 0.000001), the clinical size of the tumour (P = 0.00001), the histological grade (P = 0.01), and the estrogen receptors (P = 0.02).
  
  
  CONCLUSIONS
  In this series, the treatment was focused on surgery complemented with adjuvant radiotherapy according to node invasion and adjuvant hormonotherapy according mostly to hormonal receptors. However, the complete treatment could not be applied to all cases: only 50% of patients with node involvement were irradiated. The 5-year survival rate lower than that of younger patients may be attributed to incomplete adjuvant treatment. Specific controlled trials taking into account quality of life had to be undertaken in elderly patients in order to adjust the treatment in relation with the patients' age and physiological condition.
authors.affiliation: Service de chirurgie, centre René-Huguenin, Saint-Cloud, France.
authors.forename: J R
authors.initials: JR
authors.lastname: Garbay
authors.forename: F
authors.initials: F
authors.lastname: Bertheault-Cvitkovic
authors.forename: C
authors.initials: C
authors.lastname: Cohen-Solal Le Nir
authors.forename: D
authors.initials: D
authors.lastname: Stevens
authors.forename: P
authors.initials: P
authors.lastname: Cherel
authors.forename: J
authors.initials: J
authors.lastname: Berlie
authors.forename: J
authors.initials: J
authors.lastname: Rouesse
mesh_terms: D000367:Age Factors; D000368:Aged; D001943:Breast Neoplasms / Q000628:therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D012189:Retrospective Studies
vernacular_title: Le traitement du cancer du sein après 70 ans. A propos de 1143 cas.